Why Zai Lab Ltd - ADR’s (ZLAB) Stock Is Up 4.56%

By Aneeqa Nadeem
September 27, 2024
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Zai Lab Ltd - ADR before investing.

In this article, we go over a few key elements for understanding Zai Lab Ltd - ADR’s stock price such as:

  • Zai Lab Ltd - ADR’s current stock price and volume
  • Why Zai Lab Ltd - ADR’s stock price changed recently
  • Upgrades and downgrades for ZLAB from analysts
  • ZLAB’s stock price momentum as measured by its relative strength

About Zai Lab Ltd - ADR (ZLAB)

Before we jump into Zai Lab Ltd - ADR’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.

Want to learn more about Zai Lab Ltd - ADR’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Zai Lab Ltd - ADR.

Learn More About A+ Investor

Zai Lab Ltd - ADR’s Stock Price as of Market Close

As of September 27, 2024, 4:00 PM, CST, Zai Lab Ltd - ADR’s stock price was $23.63.

Zai Lab Ltd - ADR is up 4.56% from its previous closing price of $22.60.

During the last market session, Zai Lab Ltd - ADR’s stock traded between $20.81 and $22.87. Currently, there are 97.59 million shares of Zai Lab Ltd - ADR stock available for purchase.

Unfortunately, Zai Lab Ltd - ADR’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Zai Lab Ltd - ADR Stock Price History

Zai Lab Ltd - ADR’s (ZLAB) price is currently up 18.51% so far this month.

During the month of September, Zai Lab Ltd - ADR’s stock price has reached a high of $24.46 and a low of $18.91.

Over the last year, Zai Lab Ltd - ADR has hit prices as high as $31.22 and as low as $13.48. Year to date, Zai Lab Ltd - ADR’s stock is down 23.03%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Zai Lab Ltd - ADR Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 26, 2024, there were 6 analysts who downgraded Zai Lab Ltd - ADR’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Zai Lab Ltd - ADR’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Zai Lab Ltd - ADR’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Zai Lab Ltd - ADR’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Zai Lab Ltd - ADR (ZLAB) by visiting AAII Stock Evaluator.

Relative Price Strength of Zai Lab Ltd - ADR

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 26, 2024, Zai Lab Ltd - ADR has a weighted four-quarter relative price strength of 0.05%, which translates to a Momentum Score of 63 and is considered to be Strong.

Want to learn more about how Zai Lab Ltd - ADR is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Zai Lab Ltd - ADR Stock Price: Bottom Line

As of September 27, 2024, Zai Lab Ltd - ADR’s stock price is $23.63, which is up 4.56% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Zai Lab Ltd - ADR stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
O'Shaughnessy Tiny Titans
Screen:
23.7%
Annual Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.